Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Remarks:
The test substance (Citronellal; CAS 106-23-0) represents the racemate of the registered substance (R)-3,7-dimethyloct-6-enal (CAS 2385-77-5).
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study with acceptable restrictions

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1981
Report date:
1981
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1980

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
no
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
Citronellal
EC Number:
203-376-6
EC Name:
Citronellal
Cas Number:
106-23-0
Molecular formula:
C10H18O
IUPAC Name:
3,7-dimethyloct-6-enal
Details on test material:
- Name of test material (as cited in study report): citronellal (3,7-dimethyl-6-octenal)

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: HAGEMANN
- Weight at study initiation: 220 g (male); 170 g (female)
- Fasting period before study: 15 - 20 hours



Administration / exposure

Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Details on oral exposure:
VEHICLE
- Concentration in vehicle: from 21.5 to 50 %
- Amount of vehicle (if gavage): 10 ml/kg bw

MAXIMUM DOSE VOLUME APPLIED: 5000 mg/kg

DOSAGE PREPARATION (if unusual): administered as a 30 % aqueous emulsion in carboxymethylcellulose containing 1-2 drops of CREMOPHOR EL


Doses:
2150; 2610; 3160; 3830; 5000 mg/kg bw
No. of animals per sex per dose:
5
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: day 2-4, day7, day 13 (weighing); 1 h, 2 h, 4 h, 5 h, and then daily on working days till the end of the study (clinical observations)
- Necropsy of survivors performed: yes
Statistics:
Industrial hygiene orientating investigation (1980): FINNEY, D.J., Probitanalysis, Cambridge University Press, 3. Edition, 1971; all doses investigated used for calculation; test on homogeneity: CHI**2-value: 5.28 degree of freedom: 3; CHI**2 probability: 84.74 % homogeneity: acceptable confidence limit 95% (LD50 dose 2555 mg/kg bw) lower: 422 upper: 3307
Evaluation of data (1981): Interpolation of LD50 using the respective dosing groups leading to a mortality close to 50% (male LD50: two dosing groups; female LD50: one dosing group; male/female LD50: two dosing groups; based on original data from 1980).

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 2 423 mg/kg bw
Remarks on result:
other: interpolation from two dosing groups (1981)
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 2 555 mg/kg bw
Remarks on result:
other: including all dosing groups (1980)
Sex:
female
Dose descriptor:
LD50
Effect level:
ca. 2 150 mg/kg bw
Remarks on result:
other: including one dosing group (1981)
Sex:
male
Dose descriptor:
LD50
Effect level:
ca. 2 872 mg/kg bw
Remarks on result:
other: interpolation from two dosing groups (1981)
Gross pathology:
deceased animals: heart: acute atrial dilatation, acute venous congestion; liver: yellow confluent peripheral liver lobes
survivors: thickened gastroesophageal vestibule tip; single adhesions of liver and gastroesophageal vestibule; no findings in 2610 and 2150 mg/kg dosing groups.

Any other information on results incl. tables

Table 1: Acute toxicity - mortality

dose (mg/kg) 

5000 

3830

3160

2610 

2150 

sex

m

f

m

f

m

f

m

f

m

f

number of animals

5

5

5

5

5

5

5

deceased animals within 1 hour

0

0

0

0

0

0

0

0

0

0

on day 1    

3

4

1

4

3

3

2

3

0

2

on day 2

3

5

1

4

3

5

2

3

0

2

on day 7

3

5

1

5

3

5

2

5

0

2

on day 14

3

5

1

5

5

5

2

overall

3/5

5/5

1/5

5/5

3/5

5/5

2/5

5/5

0/5

2/5

mean body weight gain in 13 days (g)

82

-

72

-

71

-

71

-

94

35

Table 2: Acute toxicity - clinical symptoms

dose (mg/kg)

5000

3830

3160

2610

2150

dyspnoea

***

***

***

***

***

apathy

***

***

***

***

***

abnormal position

***

***

***

***

***

tumbling

***

***

***

***

***

atony

***

***

paresis hindlimb

***

***

pain reflex absence

***

cornea  reflex absence

***

anaesthesia-like state

***

tremor

***

convulsions

***

spasmic gait

***

***

fibrillar convulsions

***

***

***

clonic cramps

***

scrubby coat

***

***

***

***

***

erythema

***

***

***

exsiccosis

***

***

***

***

clotted eyes

***

stretching cramps

***

fascic convulsions

***

***

***

***

poor general condition

***

***

***

***

***

Applicant's summary and conclusion